Apollon Formularies (AQSE:APOL) EBITDA Margin % : -839.58% (As of Jun. 2023)

Apollon Formularies EBITDA Margin % Chart

Apollon Formularies Annual Data
	Trend	Jun10	Jun11	Dec12	Dec13	Dec14	Dec17	Dec18	Dec19	Dec20	Dec21
EBITDA Margin %		Get a 7-Day Free Trial					-1.06	-16.14	-	-	-1,276.26

Apollon Formularies Semi-Annual Data
	Jun11	Jun12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec17	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Jun23
EBITDA Margin %	Get a 7-Day Free Trial											-	-	-421.72	-128.48	-839.58

Competitive Comparison of Apollon Formularies's EBITDA Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Apollon Formularies's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Apollon Formularies's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Apollon Formularies's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Apollon Formularies's EBITDA Margin % falls into.

Apollon Formularies EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Apollon Formularies's EBITDA Margin % for the fiscal year that ended in Dec. 2021 is calculated as

Apollon Formularies's EBITDA Margin % for the quarter that ended in Jun. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Apollon Formularies  (AQSE:APOL) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Apollon Formularies EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Apollon Formularies's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Apollon Formularies (AQSE:APOL) Business Description